A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Abb Vie Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 39,799 shares of ABBV stock, worth $7.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,799
Previous 33,923 17.32%
Holding current value
$7.98 Million
Previous $6.18 Million 10.51%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $909,546 - $1.06 Million
5,876 Added 17.32%
39,799 $6.83 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $2,237 - $2,549
14 Added 0.04%
33,923 $6.18 Million
Q4 2023

Mar 05, 2024

SELL
$137.6 - $154.97 $170,211 - $191,697
-1,237 Reduced 3.52%
33,909 $5.25 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $251,532 - $283,285
-1,828 Reduced 4.94%
35,146 $5.45 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $876,617 - $1.01 Million
6,562 Added 21.58%
36,974 $5.51 Million
Q2 2023

Dec 12, 2023

SELL
$132.51 - $164.9 $869,530 - $1.08 Million
-6,562 Reduced 17.75%
30,412 $4.1 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $352,079 - $438,139
2,657 Added 9.57%
30,412 $4.1 Million
Q1 2023

Dec 12, 2023

SELL
$144.61 - $166.54 $1.37 Million - $1.58 Million
-9,482 Reduced 25.65%
27,492 $4.38 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $354,439 - $408,189
-2,451 Reduced 8.11%
27,755 $4.42 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $871,767 - $1.05 Million
-6,303 Reduced 17.26%
30,206 $4.88 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $100,791 - $115,601
751 Added 2.1%
36,509 $4.9 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $290,102 - $368,815
2,108 Added 6.26%
35,758 $5.48 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $462,985 - $574,435
-3,508 Reduced 9.44%
33,650 $5.46 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $202,398 - $256,092
1,884 Added 5.34%
37,158 $5.03 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $368,144 - $417,898
3,460 Added 10.88%
35,274 $3.81 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $37,033 - $41,257
352 Added 1.12%
31,814 $3.58 Million
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $163,475 - $179,966
-1,598 Reduced 4.83%
31,462 $3.41 Million
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $272,056 - $367,304
3,380 Added 11.39%
33,060 $3.54 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $149,569 - $175,545
-1,741 Reduced 5.54%
29,680 $2.6 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $215,487 - $288,354
2,937 Added 10.31%
31,421 $3.09 Million
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $17.5 Million - $26.5 Million
-271,252 Reduced 90.5%
28,484 $2.17 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $8.68 Million - $10.9 Million
-120,362 Reduced 28.65%
299,736 $26.5 Million
Q3 2019

Oct 29, 2019

SELL
$62.98 - $75.72 $237,938 - $286,070
-3,778 Reduced 0.89%
420,098 $31.8 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $17.6 Million - $22.6 Million
-268,584 Reduced 38.79%
423,876 $30.8 Million
Q1 2019

Apr 22, 2019

SELL
$77.14 - $90.79 $9.3 Million - $11 Million
-120,616 Reduced 14.83%
692,460 $55.8 Million
Q4 2018

Jan 25, 2019

SELL
$77.85 - $96.01 $254,880 - $314,336
-3,274 Reduced 0.4%
813,076 $75 Million
Q3 2018

Oct 24, 2018

BUY
$88.91 - $98.84 $1.38 Million - $1.54 Million
15,559 Added 1.94%
816,350 $77.2 Million
Q2 2018

Jul 09, 2018

BUY
$89.78 - $106.23 $2.24 Million - $2.66 Million
24,999 Added 3.22%
800,791 $74.2 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $12.2 Million - $16.4 Million
-132,757 Reduced 14.61%
775,792 $73.4 Million
Q1 2018

Apr 19, 2018

BUY
$92.01 - $123.21 $27.2 Million - $36.5 Million
295,899 Added 48.3%
908,549 $86 Million
Q4 2017

Jan 24, 2018

SELL
$89.56 - $98.21 $6.33 Million - $6.94 Million
-70,624 Reduced 10.34%
612,650 $59.2 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $47.7 Million - $61 Million
683,274
683,274 $60.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.